Today we announced that our company will acquire Acer Therapeutics Inc., effectively expanding our rare disease portfolio and accelerating our growth into a commercial company. The acquisition brings us unique rare disease commercial capabilities that will support our existing pipeline as it advances. We are encouraged by the strength of Acer’s portfolio of rare programs and are excited to foster our shared goal of bringing life changing therapeutics to patients with significant unmet needs. Join our conference call today, 8/31 at 8:30 a.m. ET to learn the details of the acquisition: https://bit.ly/47MqzQk Read the full announcement here: https://bit.ly/44FZTOE #WeAreZevra
Zevra Therapeutics
Pharmaceutical Manufacturing
Celebration, FL 9,792 followers
A Rare Approach to Therapeutics
About us
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies. With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients. Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.
- Website
-
http://www.zevra.com
External link for Zevra Therapeutics
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Celebration, FL
- Type
- Public Company
- Founded
- 2006
Locations
-
Primary
1180 Celebration Boulevard
Celebration, FL 34747, US
-
2500 Crosspark Road
Coralville, IA 52241, US
-
2200 Kraft Drive
Blacksburg , VA 24060, US
-
1001 Pennsylvania Ave, NE
13th Floor North
Waashington, DC 20004, US
Employees at Zevra Therapeutics
Updates
-
October is NPD Awareness Month 🎗️🌎 This year, we’re continuing our spotlight on the amazing Super Siblings in our community! Check out the video to learn more about how you can share your sibling’s story with us. If you have a Super Sibling and want to be part of this special initiative, we’d love to hear from you! Send us your videos so we can share them and celebrate the incredible bonds in our community. Interested? Contact Maria at [email protected], and she will send you some guidelines on how to create your video. Let’s make this October unforgettable by shining a light on our Super Siblings! 🌟 #NPDAwareness #SuperSiblings #INPDA #TogetherWeAreStronger
Niemann-Pick Disease Awareness Month
https://www.youtube.com/
-
Join us on September 22 to celebrate World Narcolepsy Day 2024. This day is dedicated to raising awareness of narcolepsy on a global scale. World Narcolepsy Day unites the international narcolepsy community to inspire action, increase public knowledge, and elevate the voices people living with narcolepsy worldwide. #ProjectSleep #WorldNarcolepsyDay
-
There is still time to join the cause! You can ride as a virtual rider or simply donate to the cause at https://lnkd.in/eWDWzWrc or by texting 'Curethecycle' to (833) 755-6550! #nucdf #curethecycle #donatenow #ureacycle #ureacycledisorders #metabolicconditions #geneticconditions
-
#NiemannPick disease type C (#NPC) is an ultra-rare, genetic, progressive and fatal neurological disease that occurs in chidlren and adults. Patients experience disease progression in speech, swallow, cognition, fine motor and mobility. Learn more: https://bit.ly/4dRucHd
-
This year the central disorders of hypersomnolence community came together for the EL-PFDD meeting to illuminate hypersomnia. The quest to further patient-owned data to accelerate research and the development of new drugs, devices, and other therapies is not over. The DREAMS Portal, a data initiative with RARE-X, a program of Global Genes, is now Live! Register and complete the 5 priority surveys by October 31, to have your voice heard in the end-of-year community insights. Register here - https://lnkd.in/guepwmKU #DREAMSportal #BeCounted #CDoH #centraldisordersofhypersomnolence #idiopathichypersomnia #KleinLevinSyndrome #narcolepsy #cataplexy #sleeprelateddisorders #idiopathichypersomnolence #hypersomnolence #sleepconsortium Hypersomnia Foundation, Project Sleep, Anne Marie Morse, PWN4PWN, Hypersomnolence Australia, Global Genes, RARE-X
-
📜 Project Sleep is leading efforts to establish a #sleep program at the CDC via the SLEEP Act! 💯 In this clip, Project Sleep’s President & CEO, Julie Flygare, JD, shares about the SLEEP Act, "Sleep Leading to Enhanced Epidemiology and Public Health." ➡️ This new act would help to create a sleep program at the CDC to enhance public health activities and collect and maintain data to better track sleep across America. Part of the bill would also address the challenges we face to educate medical providers about sleep and #sleepdisorders. 🇺🇸 This video is from “Awakening America: A Congressional Briefing on Sleep and Public Health,” which Project Sleep proudly hosted on Tuesday, July 16th, 2024. Watch the full recording now: https://lnkd.in/dUtjtGfM
-
Zevra Therapeutics presented four posters detailing clinical results from multiple studies demonstrating #arimoclomol's safety and efficacy in #NiemannPick disease type C and a poster highlighting pharmacokinetic modeling of nitrogen scavengers and #OLPRUVA in #UreaCycleDisorders. For more details on the presentation, read here: https://bit.ly/47j0d8A #SSIEM2024 #NPC #UCDs
-
Zevra Therapeutics is pleased to present 4 posters highlighting new clinical data on #arimoclomol, an investigational therapy, for #NiemannPick disease type C and 1 poster on pharmacokinetic modeling of nitrogen scavengers and #OLPRUVA for #UreaCycleDisorders at the SSIEM 2024 Annual Symposium. Find more details on the conference here: https://bit.ly/3XsAKGw #SSIEM2024 #NPC #UCDs
-
"Our ultimate goal is to provide hope and improved outcomes for patients and their families.” Cindy Parseghian https://lnkd.in/duvtWWH3